SYRS - Syros Pharmaceuticals EPS misses by $0.12 beats on revenue March, 04 2021 07:39 AM Syros Pharmaceuticals Inc. Syros Pharmaceuticals (SYRS): Q4 GAAP EPS of -$0.62 misses by $0.12.Revenue of $5.7M (+1017.6% Y/Y) beats by $3.01M.Press Release For further details see: Syros Pharmaceuticals EPS misses by $0.12, beats on revenue